Today, Vexos Inc., an electronics manufacturing and custom materials solutions company, received authorization from Health Canada for the Mechanical Ventilator Milano (MVM) ventilator.
The MVM ventilator was born out of the collaboration of a national and international team who came together to develop a ventilator model which is easy-to-produce, using off-the-shelf, easily accessible parts. Canadian Nuclear Laboratories (CNL), which operates our sites, was part of the MVM consortium and mobilized its scientists and engineers to apply their expertise in support of this important initiative.
As we continue to face challenges related to the COVID-19 pandemic, this is another example of how the global community is coming together to solve complex problems.
At AECL, we are proud to support Canada’s response to the pandemic. Our sites are home to some of Canada’s most unique and innovative facilities, laboratories, equipment and, most importantly, expertise. CNL mobilized its scientists, engineers, technical staff and facilities to contribute to the national response to COVID-19. This is a clear example of the value of these scientific capabilities and assets.
Today’s announcement paves the way for Vexos to manufacture and supply 10,000 ventilators as part of a national, made-in-Canada, effort to treat patients most severely affected by the COVID-19 virus. Vexos will now start shipping the MVM ventilators to the Government of Canada.
The MVM consortium was initiated in Italy and grew to include physicists, engineers, and business leaders from around the world, including here in Canada: Canadian Nuclear Laboratories, TRIUMF, SNOLAB, McDonald Institute, Vexos and JMP Solutions.
Regulatory authorization of the ventilator is the culmination of the ingenuity and tireless efforts of the entire MVM consortium.
I am incredibly proud of how employees at AECL and CNL, together with our partners across the country, are collaborating during this difficult and challenging time.
Richard J. Sexton
President and CEO of AECL